Ayalon: How Much Capital Headroom Is Really Left After 2025?
Ayalon enters 2026 with a strong June 2025 solvency snapshot, but that headroom already has to absorb ILS 125 million of dividends, a year-end Tier 2 repayment, and continued support for Weshur. This follow-up separates the formal cushion from the capital that is still truly free.
What This Follow-Up Is Actually Testing
The main article already established that 2025 was a much stronger year for Ayalon. Earnings improved, underwriting looked better, and the savings engine started to look more credible. This continuation isolates one question only: how much of the group’s capital cushion is still genuinely available after that year.
That matters because at an insurer, profit is not the end of the story. It still has to pass through solvency constraints, dividend policy, hybrid-capital repayments, and support for subsidiaries. In Ayalon’s case, the latest formal solvency measurement is still June 30, 2025, while year-end profit, the August and November dividends, the December 31, 2025 Tier 2 repayment, and the ongoing support for Weshur all sit on a later timeline.
The first point is that the June 2025 snapshot is genuinely strong. Without the phase-in, Ayalon reported a 129% solvency ratio and ILS 559.4 million of excess capital after material capital actions that took place between the calculation date and the reporting date. With the phase-in, the ratio was 136% and excess capital stood at ILS 675.0 million. Midroog’s January 2026 monitoring report reinforces that read and describes the margin above the board’s internal 107% target as roughly ILS 421 million.
The second point matters more: that excess is not fully free capital. Part of it is already measured after distributions, another part is still outside the latest formal solvency read, and part of it is effectively earmarked to keep Weshur above its own capital thresholds.
What Is Already Inside the Snapshot, and What Is Still Outside
One of the easiest mistakes in reading Ayalon is to look at ILS 559 million or ILS 675 million of excess capital and assume that this is the amount still sitting freely available for shareholders at the end of 2025. That is the wrong read. The annual report itself makes clear that the June 30, 2025 solvency snapshot has already been updated for some later events, but not for all of them.
In practical terms, the roughly ILS 150 million capital raise from September 2025 is already reflected in the latest formal solvency ratio. The two dividends declared after June 30, 2025, ILS 75 million and ILS 50 million, are also explicitly deducted from that measurement. So it is wrong to describe the June surplus as a pre-dividend number. On the other hand, the annual report states explicitly that a ILS 40 million Tier 2 instrument was repaid on December 31, 2025, that this repayment is not included in the reported solvency ratio, and that it is expected to reduce the ratio by about 2 percentage points.
So anyone reading 129% or 136% as the final year-end state is missing the timing issue. The number is no longer a raw June reading, because it has already been adjusted for the late-2025 dividends and the capital raise. But it is also not yet a full December 31 reading, because the year-end Tier 2 repayment is still outside it.
That timing gap is exactly where the capital-headroom question lives. It does not mean Ayalon is close to a capital wall. It does mean that the reported excess is already partly used and not yet fully updated for every later use.
| Item | Already reflected in the June 30, 2025 snapshot | Why it matters |
|---|---|---|
| Roughly ILS 150 million capital raise in September 2025 | Yes | This is one of the main drivers behind the improved solvency ratio |
| ILS 75 million and ILS 50 million dividends declared after June 30, 2025 | Yes | The reported June surplus is already measured after those distributions |
| ILS 40 million Tier 2 repayment on December 31, 2025 | No | The company says this step should reduce the ratio by about 2 percentage points |
| ILS 16 million primary-capital injection into Weshur approved in January 2026 | No | This shows the group still had to keep moving capital into the subsidiary after year-end |
There is another important nuance. Midroog’s roughly ILS 421 million “excess capital” figure is measured above Ayalon’s own 107% internal target, not above a hypothetical zero-use baseline. That number is useful because it translates the regulatory margin into a margin above management’s own operating threshold. But it still is not the same thing as unrestricted cash-equivalent capital. It is measured at a specific point in time, above a specific threshold, before the full year-end solvency picture was refreshed, and certainly before Weshur’s early-2026 support needs were folded back into the story.
Weshur Is Where Capital Headroom Stops Being Abstract
If there is one place where Ayalon’s capital headroom stops being a spreadsheet exercise and turns into a live business question, it is Weshur.
The parent can show a healthy capital surplus, but if the subsidiary still requires recurring support, then part of that surplus is not truly free. Weshur’s updated capital policy, approved in January 2026, sets a minimum solvency target of 105% for 2026 through 2028. That is not an aspirational target. It is an operating threshold. At the same time, Weshur will not distribute dividends unless it reaches 110%, and even then only if it remains at least at 107% after distribution, while also generating at least ILS 10 million of cumulative profit from ongoing operations over two years from the beginning of profit recognition.
Now connect that policy to the numbers. As of June 30, 2025, Weshur stood at 97% before later capital actions, and only 103% after them. In other words, even after the support that was already taken into account, Weshur still sat below its own operating target, and far below any level from which a dividend conversation would even begin.
The support chronology points in the same direction. In May 2025, Ayalon approved a ILS 20 million Tier 2 subordinated instrument for Weshur and a separate ILS 10 million equity injection. In November 2025, it approved another ILS 10 million equity investment. In January 2026, after the balance-sheet date, it approved a further ILS 16 million primary-capital injection, of which ILS 5 million was immediate and ILS 11 million was scheduled for May 2026.
| Date | Type of support for Weshur | Amount | What it means for Ayalon’s capital read |
|---|---|---|---|
| May 2025 | Tier 2 support | ILS 20 million | Part of the group cushion was redirected to structural support for the subsidiary |
| May 2025 | Equity injection | ILS 10 million | Direct capital support inside 2025 |
| November 2025 | Equity injection | ILS 10 million | More support was still needed in the second half |
| January 2026 | Primary capital | ILS 16 million | The dependency on group capital continued after year-end |
The correct read is not that Weshur “breaks” the Ayalon thesis. The correct read is that Weshur still turns part of the group’s capital headroom into a buffer that is being used to preserve the subsidiary’s operating flexibility. That is a very different statement. It means Ayalon’s capital position improved, but not all of that improvement is truly free for shareholders.
This Is Not a Cash Story. It Is a Capital-Freedom Story
It is worth separating liquidity from capital. On a consolidated cash basis, Ayalon does not look stressed. At the end of 2025, it held ILS 845.9 million of cash and cash equivalents, up from ILS 708.3 million at the start of the year. Cash flow from operating activities was ILS 309.7 million, and despite financing uses and dividends, the year still ended with a ILS 137.6 million increase in cash.
That distinction matters because it is easy to confuse “there is cash” with “there is freedom to distribute or shrink capital.” At an insurer, those are different things. Midroog says almost exactly that. It describes the company’s liquidity profile as weak relative to the rating because of the business mix, but still sees financial flexibility as good relative to the rating because of the improvement in capital adequacy. The same report adds that Ayalon still has additional tools, such as raising more Tier 2 capital, but using them could weigh on the financial profile and profitability.
That is the key distinction. Ayalon does not look like a company short on cash. It does look like a company that still has to manage carefully how 2025’s earnings are translated into distribution capacity, financing freedom, and continued support for Weshur without eating too much of the capital cushion that those earnings helped build.
For shareholders, the right question is therefore not whether there is or is not a capital buffer. There is. The right question is how much of it is still genuinely free once three adjustments are made:
- Dividends that are already deducted from the latest snapshot, so they cannot be counted again as future optionality.
- The December 31 Tier 2 repayment, which is still outside the latest formal solvency number.
- The fact that Weshur still does not show its own capital margin above the operating target and therefore continues to absorb part of the group cushion.
What Is Really Left for Shareholders After 2025
The conclusion of this follow-up is sharper than the optimistic surface read of 2025, but less dramatic than the bearish version.
Ayalon is not in capital distress. Quite the opposite. The last formal snapshot points to a meaningful surplus, a positive rating-outlook change, and much clearer room to manage both growth and distributions. But the capital headroom that truly remains after 2025 is narrower than the headline ILS 559 million and ILS 675 million figures suggest, because part of it has already been consumed by dividends, part of it still has to absorb the December 31 Tier 2 repayment, and part of it is effectively reserved to keep Weshur on a credible capital path.
In other words, Ayalon bought itself time and comfort. It has not yet bought itself full freedom.
That is why the next solvency report matters more than another strong earnings headline. If Ayalon shows an updated ratio that remains comfortably above target even after the year-end Tier 2 repayment, and if Weshur can move above 105% without repeatedly returning to the group wallet, then 2025’s capital story will become a cushion that truly supports dividend policy and strategic flexibility.
If not, 2025 will be remembered as the year in which earnings ran ahead of the full clean-up of the capital structure. That would still be better than the company’s earlier position. It just would not be the same thing as genuine capital freedom.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.